Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ENOS Antikörper (AA 522-705)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch ENOS in WB, IHC, ICC und IP. Er zeigt eine Reaktivität gegenüber Schwein.
Produktnummer ABIN1860034

Kurzübersicht für ENOS Antikörper (AA 522-705) (ABIN1860034)

Target

Alle ENOS (NOS3) Antikörper anzeigen
ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Reaktivität

  • 254
  • 136
  • 134
  • 14
  • 12
  • 10
  • 10
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Schwein

Wirt

  • 269
  • 32
  • 2
Kaninchen

Klonalität

  • 271
  • 32
Polyklonal

Konjugat

  • 133
  • 25
  • 15
  • 11
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
Dieser ENOS Antikörper ist unkonjugiert

Applikation

  • 248
  • 92
  • 86
  • 79
  • 64
  • 50
  • 48
  • 46
  • 33
  • 32
  • 23
  • 8
  • 7
  • 4
  • 3
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
  • Bindungsspezifität

    • 26
    • 25
    • 23
    • 19
    • 17
    • 16
    • 16
    • 10
    • 10
    • 8
    • 8
    • 7
    • 7
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 522-705

    Verwendungszweck

    Polyclonal Antibody to Endothelial NOS (eNOS)

    Spezifität

    The antibody is a rabbit polyclonal antibody raised against eNOS. It has been selected for its ability to recognize eNOS in immunohistochemical staining and western blotting.

    Aufreinigung

    Antigen-specific affinity chromatography followed by Protein A affinity chromatography

    Immunogen

    NOS3 (Ala522-Phe705)

    Isotyp

    IgG
  • Applikationshinweise

    Western blotting: 0.2-2 μg/mL,1:250-2500 Immunohistochemistry: 5-20 μg/mL,1:25-100 Immunocytochemistry: 5-20 μg/mL,1:25-100 Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    500 μg/mL

    Buffer

    PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.

    Konservierungsmittel

    Dithiothreitol (DTT), ProClin

    Vorsichtsmaßnahmen

    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

    Andere Bezeichnung

    eNOS

    Hintergrund

    NOS3, ECNOS, NOS III, E-NOS, C-NOS, ENOS, CNOS, Constitutive NOS, Nitric Oxide Synthase 3, Endothelial

    Pathways

    ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Sie sind hier:
Chat with us!